| Literature DB >> 21932611 |
Fatma Demirel1, Sevim Unal, I Ilker Çetin, Ihsan Esen, Aslihan Arasli.
Abstract
Diazoxide is the main therapeutic agent for persistent hyperinsulinemic hypoglycemia. Generally, it is tolerated well, but rarely it can cause severe life-threatening complications. We report a neonate who was treated with diazoxide for hyperinsulinemic hypoglycemia. On the 6th day of the treatment we observed sepsis-mimicking symptoms, mild pulmonary hypertension, and re-opening of the ductus arteriosus. All these findings resolved dramatically shortly after discontinuation of treatment. To our knowledge, this is the first reported case of re-opening of the ductus arteriosus due to diazoxide toxicity.Entities:
Mesh:
Substances:
Year: 2011 PMID: 21932611 DOI: 10.1515/jpem.2011.238
Source DB: PubMed Journal: J Pediatr Endocrinol Metab ISSN: 0334-018X Impact factor: 1.634